Arcturus Therapeutics (ARCT) Q1 2024 Earnings
ARCT·Reported May 8, 2024·After market close
Arcturus Therapeutics reported Q1 2024 revenue of $32.6M, beat analyst consensus of $17.5M by $15.1M. Diluted EPS came in at $-1.00, beat the $-1.17 consensus by $0.17.
Revenue
$32.6Mbeat by $15.1M
Consensus: $17.5MDiluted EPS
$-1.00beat by $0.17
Consensus: $-1.17
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about Arcturus Therapeutics's Q1 2024 earnings report.
Arcturus Therapeutics (ARCT) reported Q1 2024 earnings on May 8, 2024 after market close.
Arcturus Therapeutics reported revenue of $32.6M and diluted EPS of $-1.00 for Q1 2024.
Revenue beat the consensus estimate of $17.5M by $15.1M. EPS beat the consensus estimate of $-1.17 by $0.17.
You can read the 10-Q periodic report (0000950170-24-055702) directly on SEC EDGAR. The filing index links above go to sec.gov.